Variant report

Variant	nsv10588
Chromosome Location	chr4:152807665-152809854
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:152803724..152805338-chr4:152808624..152810923,2	K562	blood:
2	chr4:152805506..152807725-chr4:152813069..152815634,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PET112-1	chr4:152808695-152808915	XLOC_004123
2	lnc-PET112-1	chr4:152809643-152809730	XLOC_004123
3	lnc-FAM160A1-10	chr4:152808057-152810405	l_2755_chr4:152807157-152811090_testes
4	lnc-FAM160A1-10	chr4:152807158-152808055	l_2755_chr4:152807157-152811090_testes

No data

Extended variants
information (count: 78 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:78 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10018048	chr4:152807665-152807666	Weak transcription Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs571606544	chr4:152807738-152807739	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
3	rs556786412	chr4:152807772-152807773	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
4	rs575087497	chr4:152807778-152807779	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
5	rs536003719	chr4:152807829-152807830	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
6	rs202229921	chr4:152807847-152807848	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
7	rs200910403	chr4:152807848-152807849	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
8	rs201881784	chr4:152807849-152807850	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
9	rs199879324	chr4:152807855-152807856	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
10	rs142474009	chr4:152807901-152807902	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
11	rs572321269	chr4:152807905-152807906	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
12	rs575150319	chr4:152807951-152807952	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
13	rs573028796	chr4:152807977-152807978	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
14	rs552120	chr4:152808048-152808049	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
15	rs528304883	chr4:152808085-152808086	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
16	rs540640153	chr4:152808142-152808143	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
17	rs558656134	chr4:152808143-152808144	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
18	rs577311492	chr4:152808147-152808148	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
19	rs542681123	chr4:152808218-152808219	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs4282150	chr4:152808247-152808248	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs4449394	chr4:152808263-152808264	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs529013410	chr4:152808274-152808275	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs244403	chr4:152808376-152808377	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs542413440	chr4:152808381-152808382	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs17028038	chr4:152808394-152808395	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs527964024	chr4:152808421-152808422	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs537302752	chr4:152808435-152808436	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
28	rs138088272	chr4:152808446-152808447	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
29	rs141214394	chr4:152808468-152808469	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
30	rs145023745	chr4:152808475-152808476	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs181256673	chr4:152808529-152808530	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs536066959	chr4:152808637-152808638	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs78412882	chr4:152808645-152808646	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs58843921	chr4:152808677-152808678	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs563671417	chr4:152808689-152808690	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs57864042	chr4:152808694-152808695	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs558949445	chr4:152808695-152808696	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs549392983	chr4:152808698-152808699	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs577175900	chr4:152808699-152808700	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs184906403	chr4:152808709-152808710	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs556715822	chr4:152808712-152808713	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs138858925	chr4:152808759-152808760	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs542476802	chr4:152808777-152808778	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
44	rs560499234	chr4:152808874-152808875	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
45	rs528035726	chr4:152808880-152808881	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
46	rs546171279	chr4:152808882-152808883	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
47	rs17028044	chr4:152808893-152808894	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs531985892	chr4:152808948-152808949	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
49	rs550135223	chr4:152808982-152808983	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
50	rs568630467	chr4:152808983-152808984	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Breast cancer	21364760	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	17588203	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD

Chromatin state (count:58 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:152796400-152808200	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr4:152803400-152809200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
3	chr4:152804000-152808800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
4	chr4:152804000-152809000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
5	chr4:152804200-152809400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
6	chr4:152805600-152808400	Weak transcription	Fetal Thymus	thymus
7	chr4:152806400-152809200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
8	chr4:152806800-152807800	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr4:152806800-152808400	Enhancers	HUES64 Cell Line	embryonic stem cell
10	chr4:152807000-152808000	Weak transcription	GM12878-XiMat	blood
11	chr4:152807000-152808200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr4:152807000-152808400	Enhancers	HUES48 Cell Line	embryonic stem cell
13	chr4:152807000-152808600	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr4:152807200-152808200	Enhancers	iPS-15b Cell Line	embryonic stem cell
15	chr4:152807400-152808200	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr4:152807400-152808400	Weak transcription	H1 Cell Line	embryonic stem cell
17	chr4:152807400-152808400	Weak transcription	Fetal Brain Male	brain
18	chr4:152807800-152808200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
19	chr4:152808000-152808200	Enhancers	GM12878-XiMat	blood
20	chr4:152808000-152808200	Enhancers	Monocytes-CD14+_RO01746	blood
21	chr4:152808000-152808800	Enhancers	HSMM	muscle
22	chr4:152808000-152810000	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr4:152808200-152808400	Enhancers	H9 Cell Line	embryonic stem cell
24	chr4:152808200-152808600	Enhancers	iPS-20b Cell Line	embryonic stem cell
25	chr4:152808200-152808600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr4:152808200-152809600	Enhancers	Primary hematopoietic stem cells short term culture	blood
27	chr4:152808200-152809600	Enhancers	Muscle Satellite Cultured Cells	--
28	chr4:152808200-152809600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
29	chr4:152808200-152809800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr4:152808200-152810200	Enhancers	Primary B cells from peripheral blood	blood
31	chr4:152808200-152810200	Flanking Active TSS	GM12878-XiMat	blood
32	chr4:152808400-152808600	Enhancers	H1 Cell Line	embryonic stem cell
33	chr4:152808400-152808800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr4:152808400-152809000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr4:152808400-152809000	Enhancers	Fetal Brain Male	brain
36	chr4:152808400-152809400	Enhancers	Dnd41	blood
37	chr4:152808400-152809800	Enhancers	Fetal Thymus	thymus
38	chr4:152808400-152810400	Enhancers	Primary B cells from cord blood	blood
39	chr4:152808600-152809400	Enhancers	NHEK	skin
40	chr4:152808800-152810400	Enhancers	Primary T killer memory cells from peripheral blood	blood
41	chr4:152809000-152809200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr4:152809000-152809400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr4:152809000-152809600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
44	chr4:152809000-152809600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr4:152809000-152809600	Weak transcription	Fetal Brain Male	brain
46	chr4:152809000-152810000	Enhancers	Primary T cells fromperipheralblood	blood
47	chr4:152809000-152810800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
48	chr4:152809200-152809400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
49	chr4:152809200-152810000	Enhancers	Spleen	Spleen
50	chr4:152809200-152810200	Enhancers	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links